Fred Alger Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-269,112
| Closed | -$32.7M | – | 472 |
|
|
2024
Q4 | $32.7M | Sell |
269,112
-17,767
| -6% | -$2.18M | 0.16% | 97 |
|
|
2024
Q3 | $35.8M | Sell |
286,879
-31,373
| -10% | -$4.34M | 0.17% | 92 |
|
|
2024
Q2 | $50.3M | Buy |
318,252
+60,686
| +24% | +$7.8M | 0.24% | 72 |
|
|
2024
Q1 | $33.3M | Buy |
257,566
+167,231
| +185% | +$20.5M | 0.17% | 113 |
|
|
2023
Q4 | $8.71M | Buy |
90,335
+24,661
| +38% | +$2.37M | 0.05% | 195 |
|
|
2023
Q3 | $7.96M | Buy |
65,674
+9,819
| +18% | +$1.11M | 0.05% | 193 |
|
|
2023
Q2 | $6.4M | Buy |
55,855
+42,481
| +318% | +$5.48M | 0.03% | 224 |
|
|
2023
Q1 | $1.84M | Buy |
13,374
+5,852
| +78% | +$759K | 0.01% | 353 |
|
|
2022
Q4 | $975K | Buy |
+7,522
| New | +$872K | 0.01% | 380 |
|
|
2021
Q1 | – | Sell |
-10,636
| Closed | -$1.81M | – | 510 |
|
|
2020
Q4 | $1.81M | Sell |
10,636
-405,488
| -97% | -$60.1M | ﹤0.01% | 334 |
|
|
2020
Q3 | $58.4M | Sell |
416,124
-203,343
| -33% | -$30.9M | 0.17% | 130 |
|
|
2020
Q2 | $99.3M | Sell |
619,467
-134,369
| -18% | -$18.3M | 0.33% | 85 |
|
|
2020
Q1 | $73.7M | Sell |
753,836
-110,287
| -13% | -$12.6M | 0.32% | 77 |
|
|
2019
Q4 | $112M | Sell |
864,123
-89,209
| -9% | -$9M | 0.41% | 68 |
|
|
2019
Q3 | $71.8M | Sell |
953,332
-115,484
| -11% | -$13.6M | 0.28% | 89 |
|
|
2019
Q2 | $162M | Sell |
1,068,816
-14,237
| -1% | -$1.73M | 0.62% | 43 |
|
|
2019
Q1 | $129M | Sell |
1,083,053
-602,585
| -36% | -$77.5M | 0.51% | 50 |
|
|
2018
Q4 | $184M | Buy |
1,685,638
+107,278
| +7% | +$13.4M | 0.85% | 27 |
|
|
2018
Q3 | $255M | Buy |
1,578,360
+20,283
| +1% | +$2.77M | 0.96% | 24 |
|
|
2018
Q2 | $206M | Sell |
1,558,077
-81,788
| -5% | -$7.71M | 0.86% | 26 |
|
|
2018
Q1 | $121M | Buy |
1,639,865
+58,340
| +4% | +$3.89M | 0.56% | 41 |
|
|
2017
Q4 | $88M | Buy |
1,581,525
+149,712
| +10% | +$7.93M | 0.4% | 66 |
|
|
2017
Q3 | $64.9M | Buy |
1,431,813
+1,272,805
| +800% | +$50.9M | 0.3% | 78 |
|
|
2017
Q2 | $5.36M | Buy |
159,008
+35,168
| +28% | +$1.15M | 0.03% | 211 |
|
|
2017
Q1 | $3.67M | Sell |
123,840
-1,462
| -1% | -$45.2K | 0.02% | 249 |
|
|
2016
Q4 | $3.44M | Buy |
125,302
+16,590
| +15% | +$666K | 0.02% | 219 |
|
|
2016
Q3 | $6.68M | Buy |
108,712
+38,712
| +55% | +$1.17M | 0.03% | 192 |
|
|
2016
Q2 | $1.33M | Buy |
70,000
+14,000
| +25% | +$259K | 0.01% | 305 |
|
|
2016
Q1 | $1.09M | Hold |
56,000
| – | – | 0.01% | 366 |
|
|
2015
Q4 | $2.16M | Sell |
56,000
-8,400
| -13% | -$272K | 0.01% | 326 |
|
|
2015
Q3 | $2.07M | Sell |
64,400
-200
| -0.3% | -$6.79K | 0.01% | 346 |
|
|
2015
Q2 | $1.97M | Buy |
+64,600
| New | +$1.32M | 0.01% | 390 |
|
Other funds holding SRPT
ACA
FCM
Fred Alger Management's SRPT Position: Q1 2025 in Review
Fred Alger Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 269,112 shares — an estimated $32.7M sold.
Fred Alger Management first reported a position in SRPT in Q2 2015 and held it in 32 quarters. The position peaked at $255M in Q3 2018. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.
- Fred Alger Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
- Fred Alger Management sold 269,112 Sarepta Therapeutics shares in Q1 2025, an estimated $32.7M.
- Fred Alger Management first reported a position in Sarepta Therapeutics in Q2 2015 and held it in 32 quarters.
- Fred Alger Management's Sarepta Therapeutics position peaked at $255M in Q3 2018.
- 431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.
Based on Fred Alger Management's 13F filing for Q1 2025, filed 16 May 2025.